Drug Shortage Report for BREVIBLOC PREMIXED INJECTION
| Report ID | 192906 |
| Drug Identification Number | 02309238 |
| Brand name | BREVIBLOC PREMIXED INJECTION |
| Common or Proper name | BREVIBLOC PREMIXED INJECTION |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ESMOLOL HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250mL |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-05-19 |
| Actual start date | 2023-05-19 |
| Estimated end date | 2023-06-28 |
| Actual end date | 2023-06-28 |
| Shortage status | Resolved |
| Updated date | 2023-06-29 |
| Company comments | DIN 02188880, Product code CA2L9119 Brevibloc (esmolol) vial, 100mg/10ml (10mg/mL) is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-06-29 | English | Compare |
| v6 | 2023-06-28 | French | Compare |
| v5 | 2023-06-28 | English | Compare |
| v4 | 2023-06-16 | French | Compare |
| v3 | 2023-06-16 | English | Compare |
| v2 | 2023-05-23 | French | Compare |
| v1 | 2023-05-23 | English | Compare |
Showing 1 to 7 of 7